Iduronidase

Laronidase for treating mucopolysaccharidosis type I

R. P. El Dib and Pastores, G. M., Laronidase for treating mucopolysaccharidosis type I, vol. 6. pp. 667-674, 2007.

Mucopolysaccharidoses are a group of inherited metabolic diseases caused by the absence or deficiency of the lysosomal enzymes that are needed for breaking down glycosaminoglycans (GAGs). Over time, GAGs collect in cells, blood and connective tissues, and increased amounts are excreted in the urine. The result is permanent and includes progressive cell damage that affects the individual’s appearance, physical abilities, organ and system functioning and, in certain cases, mental development.

Subscribe to Iduronidase